| CAS ID: | 154447-36-6 |
| Molecular Formula: | C19H17NO3 |
| Molecular Weight: | 307.4 g/mol |
| Monoisotopic Mass: | 307.1208 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | LY-294002 |
| Analysis: | Drug repositioning mechanism analysis |
Reference Record 1
| PubMed ID | 28691020 | Target ID | T0232 |
| Uniprot ID | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | Name | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform |
| Model | vitro | Fibrosis Disease | Liver fibrosis |
| Process I | |||
| Process II | HSCs proliferation,HSCs activation,HSCs migration | ||
| Process III | prevenet collagen deposition | ||
| Mechanism | Targeting the FOG2/PI3K pathway | ||
Reference Record 2
| PubMed ID | 28194671 | Target ID | T0232 |
| Uniprot ID | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | Name | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform |
| Model | vitro,rat | Fibrosis Disease | Liver fibrosis |
| Process I | |||
| Process II | HSC activation | ||
| Process III | |||
| Mechanism | |||
Reference Record 3
| PubMed ID | 27878273 | Target ID | T0360 |
| Uniprot ID | RAC-alpha serine/threonine-protein kinase | Name | RAC-alpha serine/threonine-protein kinase |
| Model | rat | Fibrosis Disease | Idiopathic pulmonary fibrosis |
| Process I | regulate cytokines and growth factors,attenue inflammation | ||
| Process II | EMT | ||
| Process III | prevenet collagen deposition | ||
| Mechanism | Targeting PI3K/Akt signaling | ||
Reference Record 4
Reference Record 5
| PubMed ID | 24788198 | Target ID | T0232 |
| Uniprot ID | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | Name | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform |
| Model | vitro | Fibrosis Disease | Keloid |
| Process I | |||
| Process II | fibroblasts proliferation | ||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Reference Record 6
Reference Record 7
| PubMed ID | 23986222 | Target ID | |
| Uniprot ID | Name | ||
| Model | vitro | Fibrosis Disease | Idiopathic pulmonary fibrosis |
| Process I | |||
| Process II | |||
| Process III | |||
| Mechanism | |||
Reference Record 8
Reference Record 9
Reference Record 10
Reference Record 11
| PubMed ID | 18495798 | Target ID | T0232 |
| Uniprot ID | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | Name | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform |
| Model | vitro,rat | Fibrosis Disease | Renal fibrosis |
| Process I | |||
| Process II | EMT | ||
| Process III | |||
| Mechanism | Targeting PKB/Akt signaling | ||
Reference Record 12
| PubMed ID | 16841034 | Target ID | T0232 |
| Uniprot ID | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | Name | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform |
| Model | vitro | Fibrosis Disease | Keloid |
| Process I | |||
| Process II | |||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Reference Record 13
Reference Record 14
| PubMed ID | 15271999 | Target ID | T0232 |
| Uniprot ID | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | Name | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform |
| Model | vitro | Fibrosis Disease | Fibrosis |
| Process I | |||
| Process II | |||
| Process III | prevenet collagen deposition | ||
| Mechanism | Targeting IL-13 signaling | ||
Reference Record 15
| PubMed ID | 15047702 | Target ID | T0232 |
| Uniprot ID | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | Name | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform |
| Model | vitro | Fibrosis Disease | Fibrosis |
| Process I | |||
| Process II | |||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Reference Record 16
| PubMed ID | 26054450 | Target ID | |
| Uniprot ID | Name | ||
| Model | vitro | Fibrosis Disease | Keloid |
| Process I | |||
| Process II | |||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Reference Record 17
| PubChem: | 3973 |
| ChEMBL: | CHEMBL98350 |